SecBot SecBot

HOPE

HOPE BANCORP INC
Nasdaq· National Commercial Banks· Inc. DE· CIK 0001128361 Traditional Finance
$14.11 +0.04 (+0.28%)
Oct 26 4:00 PM ET · prev $14.07
Market cap
$1.8B
Small cap
Consensus
Buy
64% Buy or better · 11 analysts
Median target
$15.50
+10% · range $15.00–16.00
Next earnings
Oct 28
in 2 days · EPS est. $0.29
1 year
+32.1%
from $10.68 · Oct 27
30 days
+3.4%
from $13.64
52-week range
$9.84–14.50
−3% from high · low Nov 17
Avg volume 20D
936.5K
shares / day
Short interest
🔒 Subscribers only
Insider net
−$1.3M
0 buyers · 2 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Oct 28, 2026
Strongest NEUTRAL Hope Bancorp filed an 8-K extending CEO Kevin S. Kim's employment agreement through August 31, 2031 (initial…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $1.3M.

  • InstitutionsMIXED

    Q2 2026: 17 added (0 new), 12 trimmed or exited.

  • AnalystsBULLISH

    7 of 11 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.310 → $0.290 over 90 days. 1 up, 1 down in 30 days.

  • TrendRANGE

    2% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCDOUBLED650,059$8.9M
UBS Group AGNEAR_EXIT450,566$6.2M
Quantinno Capital Management LPADD244,390$3.3M
FIRST TRUST ADVISORS LPTRIM202,316$2.8M
JACOBS LEVY EQUITY MANAGEMENT, INCDOUBLED171,411$2.3M
Squarepoint Ops LLCDOUBLED155,861$2.1M
Qube Research & Technologies LtdDOUBLED153,905$2.1M
O'SHAUGHNESSY ASSET MANAGEMENT, LLCTRIM147,681$2.0M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 64% rate it Buy or better
Strong Buy2Buy5Hold4Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +10%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 24, 2026StoneX
INITIATE
INITIATEHold
Aug 3, 2026Keefe, Bruyette & Woods
MAINTAIN
MAINTAINMarket Perform
Jul 28, 2026DA Davidson
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$1.3M
sold · 2 insiders
DateInsiderTypeValue
Sep 1, 2026
Stenger Thomas
SEVP, Chief Risk Officer
SELL$22.8K
Aug 3, 2026
HA DAISY Y
Director
SELL$384.5K
Jun 8, 2026
Stenger Thomas
SEVP, Chief Risk Officer
SELL$19.0K
May 21, 2026
Sacchi Guido Francesco
Director
AWARD$54.0K
May 21, 2026
Kim Joon Kyung
Director
AWARD$72.0K
May 21, 2026
Zuehls Dale S.
Director
AWARD$91.8K
May 21, 2026
HA DAISY Y
Director
AWARD$54.0K
May 21, 2026
Doo Jinho
Director
AWARD$63.0K

Earnings setup

Estimates
Oct 28
reports in 2 days
$0.29
EPS estimate, this quarter
−6%
estimate change, 90 days
1↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.29$0.27–$0.31-1.7%$151.3M
Next Q$0.35$0.33–$0.37+0.7%$182.5M
Current FY$1.13$1.10–$1.17-0.2%$621.3M
Next FY$1.57$1.50–$1.63-0.6%$759.4M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 25, 2026 Clinical trial readout
🔒 Fresh data, subscribers only
Sep 1, 2026 Insider
Stenger Thomas sold 1,650 shares
SEVP, Chief Risk Officer @ $13.80 ($22.8K)
Aug 25, 2026 SEC
Hope Bancorp filed an 8-K extending CEO Kevin S. Kim's employment agreement through August 31, 2031 (initial term) and…
8-K — Impact 2/10
Aug 3, 2026 Insider
HA DAISY Y sold 26,995 shares
Director @ $14.25 ($384.5K)
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — DOUBLED
650,059 shares ($8.9M)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
450,566 shares ($6.2M)
Jun 8, 2026 Insider
Stenger Thomas sold 1,500 shares
SEVP, Chief Risk Officer @ $12.68 ($19.0K)
May 7, 2026 Event
SODIUM THIOSULFATE
Supplemental Approval — Manufacturing (CMC) — SODIUM THIOSULFATE — SOLUTION — INTRAVENOUS
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 28, 2026
Earnings date
HOPE Q3 2026 Earnings Before Market Open — 2026-10-28
Recent
Oct 25, 2026
Trial readout
🔒 Fresh data, subscribers only
Oct 18, 2026
Trial readout
T-90d Trial Readout: Autologous HB-adMSCs (Phase 2)
Trial: "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" Sponsor: Hope Biosciences Research Foundation Phase: Phase 2 | Status…
Oct 12, 2026
Trial readout
T-90d Trial Readout: Autologous HB-adMSCs (Phase 2)
Trial: "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" Sponsor: Hope Biosciences Research Foundation Phase: Phase 2 | Status…
Oct 4, 2026
Trial readout
T-90d Trial Readout: Autologous HB-adMSCs (Phase 2)
Trial: "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" Sponsor: Hope Biosciences Research Foundation Phase: Phase 2 | Status…
Oct 2, 2026
Trial readout
T-90d Trial Readout: Autologous HB-adMSCs (Phase 2)
Trial: "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis" Sponsor: Hope Biosciences Research Foundation Phase: Phase 2 | Status…

SecBot reports

3 filings · 0 bullish · 0 bearish · 1 mixed · 2 neutral
All HOPE filing & press-release reports (3)